Staff

About the Tumor Immunotherapy Program

Unique in the New York Metropolitan region, the Tumor Immunotherapy Program's dedicated, multidisciplinary team develops novel treatments that use the body's natural defenses to treat patients with cancer. Patients benefit from this translational approach, which draws upon the collaborative efforts of our laboratory research teams and clinical staff.

The Tumor Immunotherapy Program's team of doctors, nurses, and research scientists have specialized training in vaccine therapy and biotherapy. The program also educates health-care professionals in the various aspects of immunotherapy research and patient care.

Staff